‘African scientists should lead in developing an Aids jab for Africa’ MRC/UVRI and LSHTM UgandaPrEP Vacc1 December 2021Media
PrEPVacc featured in JIAS articles in Nov 2021 IMPERIAL, INS, MRC CTU at UCL, MRC/UVRI and LSHTM Uganda, MUHAS, NIMR-MMRC, SAMRCPrEP Vacc30 November 2021
Study leaders congratulate PrEPVacc teams on opening all trial sites IMPERIAL, MRC/UVRI and LSHTM UgandaPrEP Vacc5 October 2021
Activists push for continuity of HIV vaccine research MRC/UVRI and LSHTM UgandaPrEP Vacc23 September 2021Media
Mbeya begins enrolment to PrEPVacc clinical trial NIMR-MMRC, MRC/UVRI and LSHTM UgandaPrEP Vacc29 July 2021
Deutsche Welle: ‘After COVID, can researchers speed things up for HIV?’ IMPERIALPrEP Vacc19 July 2021Media
HIV R4P Virtual: HIV prevalence and incidence among female sex workers participating in a phase IIB HIV vaccine preparedness study in Dar es Salaam,Tanzania MUHASPrEP Vacc3 February 2021Research
HIV R4P Virtual: Community engagement and volunteer recruitment experiences in a HIV vaccine preparedness study in Masaka, Uganda MRC/UVRI and LSHTM UgandaPrEP Vacc2 February 2021Research
HIV R4P Virtual: Changes in risky sexual behaviour among adult men and women in an HIV vaccine preparedness study in south-western Uganda MRC/UVRI and LSHTM UgandaPrEP Vacc29 January 2021Research
HIV R4P Virtual: Recruitment of participants into an HIV vaccine preparedness study: Experiences from Masaka, Uganda MRC/UVRI and LSHTM UgandaPrEP Vacc28 January 2021Research
‘Uganda volunteers in phase III of HIV vaccine efficacy trials’ - The East African reports on start of PrEPVacc MRC/UVRI and LSHTM UgandaPrEP Vacc21 December 2020Media
First enrolments to PrEPVacc clinical trial at Masaka MRC/UVRI and LSHTM UgandaPrEP Vacc16 December 2020
PrEPVacc welcomes results of HPTN 084 injectable PrEP study MRC CTU at UCL, SAMRCPrEP Vacc11 November 2020
